Pregnancy Ultrasound
At NYU Langone, our ultrasound specialists provide imaging to monitor the health of your pregnancy.
Ultrasound Imaging | NYU Langone Health
NYU Langone provides abdominal, pelvic, and musculoskeletal ultrasound services to adults and children.
Female Pelvic Ultrasound
At NYU Langone, our specialists use the latest ultrasound technology to diagnose conditions in the female pelvis.
Obstetric–Gynecologic Ultrasound
At NYU Langone, our specialists provide a full range of obstetric and gynecologic ultrasound services.
Ultrasound Unit—OB/GYN | NYU Langone Health
Doctors at NYU Langone’s Ultrasound Unit—OB/GYN provide fetal monitoring during pregnancy.
Ultrasound Unit—OB/GYN Doctors | NYU Langone Health
Find a doctor at the Ultrasound Unit—OB/GYN at NYU Langone.
Laser Therapy & Dermabrasion for Aging Skin | NYU Langone Health
NYU Langone skin specialists use laser therapies and dermabrasion to smooth wrinkles and lines associated with aging skin.
Updated musculoskeletal ultrasound applications and techniques
The aim of this study is to prospectively acquire clinical ultrasound data utilizing newer versions of preexisting US applications performed with a Siemens Acuson Sequoia system, updated acquisition protocols, sequences, and transducers. This will be performed as part out the routine standard of clinical care.
Ultrasound Channel Data Analysis Using Advanced Analytics and Deep Learning
Through the collection and analysis of the ultrasound channel data using advanced analytics and deep learning will provide new information previously unavailable that may improve the sensitivity and specificity of ultrasound in HCC detection and in the detection/quantification of liver fat and iron and may also improve diagnostic efficacy of ultrasound in the detection of HCC and assessment of chronic liver diseases through the use of channel data. Once the utility of channel data is determined in the setting of liver disease, its applications may potentially be applied to other organ systems.
A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic NSCLC KaRAnaSa (ISA-4)
This is a study in which patients have a specific change in their cancer cells called a KRAS G12C mutation, which means one tiny part of a gene (KRAS) has been changed in a way that may cause the cancer to grow. In this study, two medicines, Amivantamab and Olomorasib, are used together to treat this type of lung cancer (KRAS G12C-mutated metastatic NSCLC). Amivantamab is a special type of antibody that blocks two cancer related proteins (EGFR and MET) to stop cancer cell signaling. Olomorasib is an experimental medicine that blocks the KRAS G12C protein in cancer cells. This study consists of two parts: part one (combination dose selection) and part two (expansion). In Part one of the study, patients will be given the two medicines together to find the safest and most effective dose. Part two will see how well the two medicines work at the chosen dose to fight the cancer and slow down or prevent the growth of tumors. All patients will have frequent medical check ups and blood samples taken to see how their bodies are handling the study medicine. The study team will have special scans done for all patients to see how the cancer isresponding to the study medicines. The study team will be monitoring the patients for potential side effects and safety concerns.